Invesco Ltd.
CIK 914208 · last filed 2026-09-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
EVFM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 2500
ATLANTA, GA 30309
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Evofem Biosciences, Inc. (EVFM) Delisted | 10%+ Owner | 6,636 | $0.01 | $54 | $23.66M | 5 | 2020-06-09 |
Recent Filings · Page 2 of 3
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-02 | — | Mixed | +6,358 | $179.6K | |
| 2025-02-04 | — | Mixed | +3,936 | $111.5K | |
| 2025-01-02 | — | Mixed | +2,864 | $81.5K | |
| 2024-11-05 | — | Grant (A) | +126,021 | $3.19M | |
| 2024-11-04 | — | Mixed | +2,416 | $69.5K | |
| 2024-10-02 | — | Mixed | +2,828 | $81.9K | |
| 2024-09-03 | — | Mixed | +2,612 | $76.1K | |
| 2024-08-05 | — | Grant (A) | +84,994 | $2.14M | |
| 2020-06-09 | Evofem Biosciences, Inc. (EVFM) Delisted | Mixed | +858,066 | $2.96M | EDGAR |
| 2019-06-12 | Evofem Biosciences, Inc. (EVFM) Delisted | Mixed | +2,222,222 | $10.00M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.